AdaptHealth Corp. (AHCO) stock soared 23.04% in Tuesday's pre-market trading session, driven by the company's impressive fourth-quarter 2024 financial results and positive outlook for 2025.
The medical equipment and services provider reported better-than-expected Q4 earnings, with net revenue of $856.65 million, beating the analyst consensus estimate of $829.19 million. AdaptHealth's net income of $51.4 million and earnings per share of $0.34 also exceeded Wall Street expectations, reflecting strong demand for the company's products and services.
The strong financial performance was backed by AdaptHealth's strategic initiatives, such as its "One Adapt" program aimed at enhancing operational efficiency and increasing clinical relevance. The company's focus on accelerating the application of AI and automation also contributed to its positive results.
Looking ahead, AdaptHealth provided an optimistic outlook for fiscal 2025, forecasting net revenue in the range of $3.22 billion to $3.36 billion, surpassing analysts' estimates of $3.33 billion. The company also expects to generate Adjusted EBITDA between $670 million and $710 million, and free cash flow ranging from $180 million to $220 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。